The U.S. ECMO (Extracorporeal Membrane Oxygenation) machine market was valued at USD 79.9 million in 2023 and is projected to grow at a CAGR of 5.40% from 2024 to 2030. This growth is primarily driven by the increasing incidence of cardiopulmonary and respiratory diseases, as well as a rising number of patients suffering from chronic obstructive pulmonary disease (COPD). As these conditions become more prevalent, there is a growing demand for ECMO machines, which are critical in providing life-saving support for patients with severe heart and lung dysfunction.

Moreover, the continued technological advancements in ECMO machines are making them more efficient and user-friendly. These innovations are enhancing the machines' capabilities and driving greater adoption among healthcare professionals, further fueling the market's growth. The ability of ECMO systems to provide extracorporeal life support, especially in emergency and critical care situations, has become indispensable in modern healthcare, contributing significantly to the market's expansion.

In 2023, the U.S. ECMO machine market accounted for 26.0% of the global ECMO machine market. The rise in respiratory diseases, including conditions like COPD, asthma, and lung cancer, is expected to further fuel the growth of the market. These diseases significantly affect individuals' respiratory function, leading to an increased demand for advanced life-support systems such as ECMO. The demand for ECMO machines is anticipated to continue rising as the number of patients requiring respiratory assistance grows.

One of the major drivers for the growth of the U.S. ECMO market is the high prevalence of COPD, which is the third most common cause of death in the United States, following cancer and cardiac diseases. According to the American Lung Association, over 11 million people in the U.S. are diagnosed with COPD each year. The high incidence of COPD directly translates into a greater need for life-support systems like ECMO, which help patients with severe respiratory failure. Given the rising demand, the availability of ECMO machines in healthcare facilities is struggling to meet the need, further intensifying the market's growth.

Curious about the U.S. ECMO Machine Market? Download your FREE sample copy now and get a sneak peek into the latest insights and trends. 

Key U.S. ECMO Machine Company Insights

The U.S. Extracorporeal Membrane Oxygenation Machine industry competition is expected to intensify due new product development, advancement in existing products, and the implementation of price reduction strategies. Companies are likely to focus on increasing their market share by enhancing marketing efforts through the sales teams of respective players. Additionally, collaborations and partnerships among key industry players are anticipated to drive aggressive competition in the market over the forecast period.

Key U.S. ECMO Machine Companies:

• Inspira

• Abbott

• Terumo Cardiovascular Systems Corporation

• CytoSorbents Corporation

• Cyberonics, Inc

• OriGen

• GOHIBIC™

• Agilent Technologies

• Soma Tech Intl

• Mott Corporation

Recent Developments

• In 2023, Abbott obtained two new clearances from the U.S. Food and Drug Administration (FDA) for its renowned life support system, notably the CentriMag Blood Pump. These FDA approvals enable longer-term use in adults requiring extracorporeal membrane oxygenation (ECMO), a crucial life support technique for individuals experiencing heart and lung complications.

• In July 2022, Inspira Technologies OXY B.H.N Ltd. introduced the "Liby" System, an innovative life support system aimed at addressing life-threatening heart and lung failure in patients. This advanced technology represents a significant development in the field of life support and is designed to cater to individuals facing critical heart and lung issues.

Browse through Grand View Research's Medical Devices Industry Research Reports.

• U.S. Surgical Dressings Market: The U.S. surgical dressings market size was estimated at USD 1.52 billion in 2024 and is expected to grow at a CAGR of 4.09% from 2025 to 2030.

• Canada Contrast Media Market: The Canada contrast media market size was valued at USD 198.1 million in 2024 and is projected to witness a CAGR of 6.6% from 2025 to 2030, driven by increasing demand for advanced diagnostic imaging techniques and the rising prevalence of chronic diseases.

U.S. ECMO Machine Market Report Segmentation

Grand View Research has segmented the U.S. ECMO machine market reportbased on component, modality, patient type, and application:

Component Outlook (Revenue, USD Million, 2018 - 2030)

• Pumps

• Oxygenators

• Controllers

• Cannula

• Accessories

Modality Outlook (Revenue, USD Million, 2018 - 2030)

• Veno-Arterial

• Veno-Venous

• Arterio-Venous

Patient Type Outlook (Revenue, USD Million, 2018 - 2030)

• Neonates

• Pediatric

• Adult

Application Outlook (Revenue, USD Million, 2018 - 2030)

• Respiratory

o Neonates

o Pediatric

o Adult

• Cardiac

o Neonates

o Pediatric

o Adult

• ECPR

o Neonates

o Pediatric

o Adult

Order a free sample PDF of the U.S. ECMO Machine Market Intelligence Study, published by Grand View Research.